Daniel R. Chevallard is Chief Financial Officer of Graphite Bio, Inc.. Currently has a direct ownership of 3,188 shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on May 14, 2024, when has been sold 3,188 shares (Common Stock) at a price of $15.68 per share, resulting in proceeds of $49,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.19K
0% 3M change
n/a 12M change
Total Value Held $0

Daniel R. Chevallard Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 14 2024
BUY
Open market or private purchase
$49,987 $15.68 p/Share
3,188 Added 50.0%
3,188 Common Stock

Also insider at

VIRX
Viracta Therapeutics, Inc. Healthcare
DRC

Daniel R. Chevallard

Chief Financial Officer
Cardiff, CA

Track Institutional and Insider Activities on GRPH

Follow Graphite Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRPH shares.

Notify only if

Insider Trading

Get notified when an Graphite Bio, Inc. insider buys or sells GRPH shares.

Notify only if

News

Receive news related to Graphite Bio, Inc.

Track Activities on GRPH